Q4 2025 KP Tissue Inc Earnings Call Transcript
Key Points
- KP Tissue Inc (KPTSF) reported a strong year with revenue growth and increased profitability in 2025.
- Adjusted EBITDA grew more than 25% year over year, reaching $84.2 million in Q4 2025.
- Revenue in Canada increased by 5.1% and in the US by 2.2% year over year, showing diversified growth.
- The company achieved record safety results across its manufacturing assets in 2025.
- KP Tissue Inc (KPTSF) successfully expanded its market share in Canada for both bathroom and facial tissues.
- The company faces ongoing economic uncertainty, particularly in the away from home segment.
- Pulp prices are expected to trend upwards in 2026, which could impact costs.
- Higher SG&A expenses, elevated freight and warehousing costs, and increased marketing expenses affected profitability.
- Revenue in the US declined sequentially by 2.3% in Q4 2025.
- The company anticipates a potential increase in leverage ratio due to upcoming capital expenditures for new projects.
Good morning and welcome to KP Tissue's fourth quarter 2025 results conference call. Note that today's call is being recorded for replay. (Operator Instructions)
I will now turn the call over to Doris Grbic, director of investor relations. You may begin your conference.
Thank you, operator. Good morning, everyone, and thank you for joining us to review Kruger Products fourth quarter 2025 financial results. With me this morning is Dino Bianco, the CEO of KP Tissue and Kruger Products, and Michael Keays, the CFO of KP Tissue and Kruger Products.
Today's discussion will include certain forward-looking statements. Actual results could differ materially from these forward-looking statements due to known and unknown risks and uncertainties. A list of risk factors can be found in our public filing. In addition, today's discussion will include certain non-GAAP financial measures. The reconciliation of these non-GAAP financial measures to the most comparable GAAP measure can be found in our MD
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
